Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers.

Katrin Beyer1

  • 1Department of Pathology, Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona, 08916 Badalona, Barcelona, Spain. katrinbeyer@hotmail.com

Acta Neuropathologica
|July 18, 2006
PubMed
Summary

Alpha-synuclein aggregation drives synucleinopathies. This review explores how alpha-synuclein

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the genetic architecture of non-Huntington chorea: a biobank-scale study of rare variants and repeat expansions.

NPJ genomic medicine·2026
Same author

14-3-3σ up-regulation in the temporal cortex associates with tau pathology and reactive astroglia in Lewy body disorders.

Brain pathology (Zurich, Switzerland)·2025
Same author

Does Platelet Transcriptome Dysregulation Across the Lewy Body Continuum Mirror Neuronal Dysfunction?

International journal of molecular sciences·2025
Same author

Platelet and immune cell crosstalk in dementia with Lewy bodies: Is there a unique inflammatory profile?

Journal of neuroimmunology·2025
Same author

Platelet miRNAs as early biomarkers for progression of idiopathic REM sleep behavior disorder to a synucleinopathy.

Scientific reports·2025
Same author

Key motor and non-motor features in early dementia with Lewy bodies.

Frontiers in neurology·2025

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Alpha-synuclein aggregation is a central event in synucleinopathies.
  • The precise mechanisms driving early aggregation remain unclear.
  • Alpha-synuclein's intrinsic structure and synaptic localization are implicated.

Purpose of the Study:

  • To review current knowledge on alpha-synuclein structure.
  • To summarize the role of posttranslational modifications in aggregation.
  • To explore alternative splicing as a factor in alpha-synuclein aggregation.

Main Methods:

  • Review of existing literature on alpha-synuclein.
  • Analysis of studies on posttranslational modifications (phosphorylation, oxidation, sumoylation).
  • Examination of research on alternative splicing and alpha-synuclein isoforms.

Related Experiment Videos

Main Results:

  • Posttranslational modifications significantly influence alpha-synuclein aggregation.
  • Alternative splicing generates isoforms (e.g., alpha-synuclein 112, 1126) with altered properties.
  • These isoforms may possess modified functions and aggregation propensities.

Conclusions:

  • Alpha-synuclein structure, posttranslational modifications, and alternative splicing are key factors.
  • These mechanisms likely enhance alpha-synuclein aggregation in synucleinopathies.
  • Further research is needed to fully elucidate these aggregation pathways.